Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Experimental & Molecular Medicine ; : 162-172, 2006.
Artigo em Inglês | WPRIM | ID: wpr-15695

RESUMO

People with upper body or visceral obesity have a much higher risk of morbidity and mortality from obesity-related metabolic disorders than those with lower body obesity. In an attempt to develop therapeutic strategies targeting visceral obesity, depot- specific differences in the expression of genes in omental and subcutaneous adipose tissues were investigated by DNA array technology, and their roles in adipocyte differentiation were further examined. We found that levels of metallothionein-II (MT-II) mRNA and protein expression were higher in omental than in subcutaneous adipose tissues. The study demonstrates that MT-II may play an important role in adipocyte differentiation of 3T3L1 preadipocytes, and that N-acetylcysteine (NAC) inhibits the adipocyte differentiation of 3T3L1 cells by repressing MT-II in a time- and dose-dependent manner. Furthermore, the intraperitoneal administration of NAC to rats and mice resulted in a reduction of body weights, and a marked reduction in visceral fat tissues. These results suggest that MT-II plays important roles in adipogenesis, and that NAC may be useful as an anti-obesity drug or supplement.


Assuntos
Ratos , Pessoa de Meia-Idade , Camundongos , Masculino , Humanos , Feminino , Animais , Idoso , Vísceras/efeitos dos fármacos , Fatores de Tempo , Gordura Subcutânea/efeitos dos fármacos , Ratos Sprague-Dawley , Camundongos Endogâmicos C57BL , Metalotioneína/genética , Regulação para Baixo/efeitos dos fármacos , Relação Dose-Resposta a Droga , Diferenciação Celular/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Fármacos Antiobesidade/farmacologia , Tecido Adiposo/citologia , Adipócitos/citologia , Acetilcisteína/farmacologia , Células 3T3-L1
2.
Indian J Exp Biol ; 1992 May; 30(5): 413-7
Artigo em Inglês | IMSEAR | ID: sea-58439

RESUMO

The effect of taurine on the serum and liver cholesterol and triglyceride levels was studied in rats fed cholesterol plus cholic acid. Four groups of 4 weeks old rats were fed control diet, hypercholesterolemic diet (HCD), HCD + 1% taurine or HCD + 2% taurine for 8 weeks. Addition of taurine in HCD diet showed a significant reduction not only in serum total cholesterol and triglyceride levels but also in liver total cholesterol, lipid and triglyceride contents compared to the animals fed HCD alone. Histological examination of organs of these animals showed severe fatty vacuolation in livers and signet ring type vacuolation in kidneys of rats fed HCD. Taurine showed ameliorating effect on these abnormalities. The animals fed taurine in HCD also showed increased bile and sterol excretion in faeces compared to rats fed HCD alone. Taurine showed significant hypocholesterolemia in rats probably by enhancing the catabolism of cholesterol and reducing the absorption of dietary cholesterol.


Assuntos
Animais , Hipolipemiantes/farmacologia , Colesterol/análise , Colesterol na Dieta/administração & dosagem , Ácido Cólico , Ácidos Cólicos/administração & dosagem , Dieta Aterogênica , Feminino , Hipercolesterolemia/prevenção & controle , Fígado/química , Masculino , Ratos , Ratos Wistar/metabolismo , Taurina/administração & dosagem , Triglicerídeos/análise , Vísceras/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA